GARY BOGGS: Open Payments
NPI 1194219584 · MCCOMB, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 31 payments from 13 companies in 2025. Trend: 2023 $363 · 2024 $1,186 · 2025 $833
Food & beverage: $833
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 5 | $159 |
| GlaxoSmithKline, LLC. | 9 | $146 |
| Abbott Laboratories | 1 | $134 |
| Mallinckrodt Hospital Products Inc. | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Viatris Specialty LLC | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| 3B Medical, Inc. | 1 | $17 |
Products named: NUZYRA, TRELEGY ELLIPTA, ESPRIT, ACTHAR, OFEV, GLASSIA, TEZSPIRE, AIRSUPRA.
Industry payments across MS — which companies pay providers there.
